Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV
Plain-English Summary
The Health And Human Services is looking for role of glucagon-like peptide-1 (glp-1) receptor agonists versus dpp-4 inhibitors for alcohol and substance use disorders in improving hiv-related outcomes and providing health benefits in people living with hiv. This is a no set aside used contract, meaning only qualifying small businesses can bid. Responses are due in 3 days (July 30, 2026). Work to be performed in Bethesda, Maryland.
Contract Details
- Solicitation #
- 75N95026R0007
- Type
- Combined Synopsis/Solicitation
- NAICS Code
- 541690
- PSC Code
- B529
- Posted
- July 27, 2026
- Response Deadline
- July 30, 2026
Agency & Contact
- Department
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Sub-agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Point of Contact
Who Should Bid
- Businesses classified under NAICS 541690
- Businesses qualifying for No Set aside used
- Must be registered in SAM.gov with active status
- Must have relevant past performance or capability statement
- Able to perform work in Maryland
Tips for Winning This Contract
- ⚡ Deadline is soon — start your response immediately if interested
- Contact the contracting officer with questions BEFORE the deadline — they want to help qualified bidders
- Review the full solicitation documents on SAM.gov for detailed requirements
- Check if there's an industry day or Q&A session listed
Download attachments, full requirements, and submit your response on SAM.gov
Similar Opportunities
USMMA - Industrial Hygienist
Rivercane Site Suitability Assessment for Post-Hurricane Helene Recovery
SMR Consultant for Hungary for USEU Mission
Historical studies of properties owned by the US Government in Paris and Marseille, France
VACCHCS Life Savings Drawings